Skip to main content
Premium Trial:

Request an Annual Quote

CloudScientific to Distribute Golden Helix's Genetic-Analysis Software in China


This article has been changed to correct an error in the original report. CloudScientific will distribute GoldenHelix's software not vice versa.

CloudScientific, a Chinese life science-software company will distribute in China a data-management and -analysis software suite developed by Golden Helix .

The SNP & Variation suite contains modules for copy-number analysis, whole-genome analysis, and regression, among others.

Together, the modules enable researchers to manage, process, analyze, and map SNPs and copy number variations in genome-wide association studies.

"China is experiencing explosive growth in genetic research," and CloudScientific will be able to provide the market with "exceptional analytic capabilities for genetic research," CloudScientific CEO Jack Lin said in a statement.

Andrew Ferrin, Golden Helix's executive vice president of business development, said his company receives "more inquiries from China than any other country" except for the US and Canada.

CloudScientific spun out of InforSense, which was acquired by IDBS last year. It provides software for bioinformatics, cheminformatics, molecular modeling, computational chemistry, toxicology, and pre-clinical and clinical data-analysis and -management.

Additional details of the agreement were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.